RHOLISTIX
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 May 2023)
What this means for you
This application is over — abandoned 29 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88401759
- Mark type
- Stylized text
- Filed
- 25 Apr 2019
- Published for opposition
- 03 Mar 2020
- Abandoned
- 29 May 2023
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations, namely, Anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease
Owner
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
Prosecution history
- 30 May 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 May 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2022 — SOU EXTENSION 5 GRANTED
- 25 Oct 2022 — SOU EXTENSION 5 FILED
- 02 Nov 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 23 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Apr 2022 — SOU EXTENSION 4 GRANTED
- 21 Apr 2022 — SOU EXTENSION 4 FILED
- 21 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 23 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Oct 2021 — SOU EXTENSION 3 GRANTED
- 21 Oct 2021 — SOU EXTENSION 3 FILED
- 21 Oct 2021 — SOU TEAS EXTENSION RECEIVED